# Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers

> **NCT05515731** · PHASE4 · COMPLETED · sponsor: **Alaa Gamal** · enrollment: 14 (actual)

## Conditions studied

- Cornea Ulcer

## Interventions

- **BIOLOGICAL:** Autologous platelet-rich plasma (PRP) eye drops

## Key facts

- **NCT ID:** NCT05515731
- **Lead sponsor:** Alaa Gamal
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05515731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05515731, "Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05515731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*